Episode 58
Biotech Hangout
00:00
Morphology Data: The Challenges and Opportunities
Rob Pervene: I think we're all really curious to hear more about morphic data and I'll have us, Josh to sort of lead with some questions. So being able to get a very specific molecule, because it has to hit alpha four beta seven. This is a blocker of T cell lymphocytes and transmigration has got to hit out for beta seven block that, but not block alpha four beta one. That just makes it commercially not viable with when you're talking about ulcerative colitis or crones. But the hard part here is not seeing the opportunity. The opportunity is actually fairly straightforward.
Transcript
Play full episode
